This study is designed to provide safety and efficacy data to support the development of CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of methotrexate.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00847613?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
